BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22722553)

  • 1. Molecular targeted therapy in hepatocellular carcinoma: present achievements and future challenges.
    Giacomin A; Sergio A; Vanin V; Gazzola A; Cazzagon N; Farinati F
    Dig Dis; 2012; 30(3):284-8. PubMed ID: 22722553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling pathway and molecular-targeted therapy for hepatocellular carcinoma.
    Kudo M
    Dig Dis; 2011; 29(3):289-302. PubMed ID: 21829020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic therapies in hepatocellular carcinoma.
    Wörns MA; Weinmann A; Schuchmann M; Galle PR
    Dig Dis; 2009; 27(2):175-88. PubMed ID: 19546557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latest developments in targeted therapy for hepatocellular carcinoma.
    Montella L; Addeo R; Caraglia M; Del Prete S
    Expert Rev Anticancer Ther; 2010 Oct; 10(10):1635-46. PubMed ID: 20942634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signaling pathways in hepatocellular carcinoma.
    Sia D; Villanueva A
    Oncology; 2011; 81 Suppl 1():18-23. PubMed ID: 22212931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatocellular carcinoma: molecular pathogenesis and novel targets for therapy].
    Marquardt JU; Galle PR; Teufel A
    Dtsch Med Wochenschr; 2012 Apr; 137(16):855-60. PubMed ID: 22495921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted therapy of hepatocellular cancer.
    Wysocki PJ
    Expert Opin Investig Drugs; 2010 Feb; 19(2):265-74. PubMed ID: 20074016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted therapy of hepatocellular carcinoma: present and future.
    Chan SL; Yeo W
    J Gastroenterol Hepatol; 2012 May; 27(5):862-72. PubMed ID: 22369685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting signaling pathways in hepatocellular carcinoma: new perspectives in medical therapy.
    Fornaro L; Vivaldi C; Caparello C; Sacco R; Rotella V; Musettini G; Luchi S; Baldini EE; Falcone A; Masi G
    Future Oncol; 2014 Feb; 10(2):285-304. PubMed ID: 24490614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular targeted therapy for hepatocellular carcinoma: bench to bedside.
    Kudo M
    Dig Dis; 2011; 29(3):273-7. PubMed ID: 21829017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now.
    Pang RW; Poon RT
    Oncology; 2007; 72 Suppl 1():30-44. PubMed ID: 18087180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biological implication of cancer stem cells in hepatocellular carcinoma: a possible target for future therapy.
    Sukowati CH; Tiribelli C
    Expert Rev Gastroenterol Hepatol; 2013 Nov; 7(8):749-57. PubMed ID: 24161136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future treatment option for hepatocellular carcinoma: a focus on brivanib.
    Kudo M
    Dig Dis; 2011; 29(3):316-20. PubMed ID: 21829023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling networks in human hepatocarcinogenesis--novel aspects and therapeutic options.
    Breuhahn K; Schirmacher P
    Prog Mol Biol Transl Sci; 2010; 97():251-77. PubMed ID: 21074736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic chemotherapy of hepatocellular carcinoma--Korean experience.
    Lee HC
    Oncology; 2008; 75 Suppl 1():114-8. PubMed ID: 19092280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatocellular carcinoma].
    Kondo S; Ueno H; Morizane C; Okusaka T
    Gan To Kagaku Ryoho; 2010 Jul; 37(7):1219-23. PubMed ID: 20647702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathogenesis and targeted therapy of hepatocellular carcinoma.
    Zender L; Kubicka S
    Onkologie; 2008 Oct; 31(10):550-5. PubMed ID: 18854656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib.
    Yau T; Pang R; Chan P; Poon RT
    Expert Opin Pharmacother; 2010 Sep; 11(13):2187-98. PubMed ID: 20707757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting fibroblast growth factor receptor signaling in hepatocellular carcinoma.
    Cheng AL; Shen YC; Zhu AX
    Oncology; 2011; 81(5-6):372-80. PubMed ID: 22269894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of growth factor signaling in human hepatocellular carcinoma.
    Breuhahn K; Longerich T; Schirmacher P
    Oncogene; 2006 Jun; 25(27):3787-800. PubMed ID: 16799620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.